"COS Cells" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
CELL LINES derived from the CV-1 cell line by transformation with a replication origin defective mutant of SV40 VIRUS, which codes for wild type large T antigen (ANTIGENS, POLYOMAVIRUS TRANSFORMING). They are used for transfection and cloning. (The CV-1 cell line was derived from the kidney of an adult male African green monkey (CERCOPITHECUS AETHIOPS).)
| Descriptor ID |
D019556
|
| MeSH Number(s) |
A11.251.210.172.500 A11.329.228.220
|
| Concept/Terms |
COS Cells- COS Cells
- COS Cell
- Cell, COS
- Cells, COS
COS-7 Cells- COS-7 Cells
- COS 7 Cells
- COS-7 Cell
- Cell, COS-7
- Cells, COS-7
COS-1 Cells- COS-1 Cells
- COS 1 Cells
- COS-1 Cell
- Cell, COS-1
- Cells, COS-1
|
Below are MeSH descriptors whose meaning is more general than "COS Cells".
Below are MeSH descriptors whose meaning is more specific than "COS Cells".
This graph shows the total number of publications written about "COS Cells" by people in this website by year, and whether "COS Cells" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 0 | 1 | 1 |
| 1999 | 0 | 1 | 1 |
| 2000 | 0 | 4 | 4 |
| 2001 | 0 | 1 | 1 |
| 2002 | 0 | 3 | 3 |
| 2003 | 0 | 2 | 2 |
| 2004 | 0 | 5 | 5 |
| 2005 | 0 | 7 | 7 |
| 2006 | 0 | 3 | 3 |
| 2007 | 0 | 6 | 6 |
| 2009 | 0 | 4 | 4 |
| 2011 | 0 | 8 | 8 |
| 2012 | 0 | 2 | 2 |
| 2013 | 0 | 4 | 4 |
| 2014 | 0 | 2 | 2 |
| 2015 | 0 | 1 | 1 |
| 2016 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "COS Cells" by people in Profiles.
-
Jenkins LM, Singh P, Varadaraj A, Lee NY, Shah S, Flores HV, O'Connell K, Mythreye K. Altering the Proteoglycan State of Transforming Growth Factor ? Type III Receptor (T?RIII)/Betaglycan Modulates Canonical Wnt/?-Catenin Signaling. J Biol Chem. 2016 Dec 02; 291(49):25716-25728.
-
Ali YO, Allen HM, Yu L, Li-Kroeger D, Bakhshizadehmahmoudi D, Hatcher A, McCabe C, Xu J, Bjorklund N, Taglialatela G, Bennett DA, De Jager PL, Shulman JM, Bellen HJ, Lu HC. NMNAT2:HSP90 Complex Mediates Proteostasis in Proteinopathies. PLoS Biol. 2016 06; 14(6):e1002472.
-
Meghdari M, Gao N, Abdullahi A, Stokes E, Calhoun DH. Carboxyl-terminal truncations alter the activity of the human a-galactosidase A. PLoS One. 2015; 10(2):e0118341.
-
Meiler S, Baumer Y, Toulmin E, Seng K, Boisvert WA. MicroRNA 302a is a novel modulator of cholesterol homeostasis and atherosclerosis. Arterioscler Thromb Vasc Biol. 2015 Feb; 35(2):323-31.
-
McGoldrick CA, Jiang YL, Paromov V, Brannon M, Krishnan K, Stone WL. Identification of oxidized protein hydrolase as a potential prodrug target in prostate cancer. BMC Cancer. 2014 Feb 10; 14:77.
-
Qu Q, Qu J, Zhan M, Wu LX, Zhang YW, Lou XY, Fu LJ, Zhou HH. Different involvement of promoter methylation in the expression of organic cation/carnitine transporter 2 (OCTN2) in cancer cell lines. PLoS One. 2013; 8(10):e76474.
-
Costantini L, Snapp E. Probing endoplasmic reticulum dynamics using fluorescence imaging and photobleaching techniques. Curr Protoc Cell Biol. 2013 Sep 24; 60:21.7.1-21.7.29.
-
Heckler EJ, Crassous PA, Baskaran P, Beuve A. Protein disulfide-isomerase interacts with soluble guanylyl cyclase via a redox-based mechanism and modulates its activity. Biochem J. 2013 May 15; 452(1):161-9.
-
Yudowski GA, Olsen O, Adesnik H, Marek KW, Bredt DS. Acute inactivation of PSD-95 destabilizes AMPA receptors at hippocampal synapses. PLoS One. 2013; 8(1):e53965.
-
Han X, Tachado SD, Koziel H, Boisvert WA. Leu128(3.43) (l128) and Val247(6.40) (V247) of CXCR1 are critical amino acid residues for g protein coupling and receptor activation. PLoS One. 2012; 7(8):e42765.